Lanean...
Thioredoxin decreases anthracycline cardiotoxicity, but sensitizes cancer cell apoptosis
Cardiotoxicity is a major limitation for anthracycline chemotherapy although anthracyclines are potent antitumor agents. The precise mechanism underlying clinical heart failure due to anthracycline treatment is not fully understood, but is believed to be due, in part, to lipid peroxidation and the g...
Gorde:
| Argitaratua izan da: | Cardiovasc Toxicol |
|---|---|
| Egile Nagusiak: | , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2020
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7854973/ https://ncbi.nlm.nih.gov/pubmed/32880787 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12012-020-09605-2 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|